Member Info for itsallamess

This website has done this a few times, stopped updating.

I'm looking on https://www.londonstockexchange.com/exchange/prices-and-markets/stocks/exchange-insight/trade-data.html?page=0&pageOffBook=0&fourWayKey=FI4000153309GBGBXASQ1&formName=frmRow&upToRow=-1

Looks like a wrong trade put though thennit was cancelled

15:06:16 23-Mar-2020 549.00 GBX 2,150 11,803.50 Cancelled CANC AIMX
15:06:16 23-Mar-2020 549.00 GBX 2,150 11,803.50 Off-book AIMX

2 one codes in
Rns on it's way?

14:47:24 23-Mar-2020 465.00 GBX 1 4.65
14:29:55 23-Mar-2020 458.00 GBX 1 4.58

Very valid comment from some on a finish BB
https://keskustelu.kauppalehti.fi/5/i/keskustelu/thread.jspa?messageID=8076750

"If the drug is ready, why are product costs in the millions?

If safety has been established in the past, even though the results were disappointing, why can't the substance be helped helped by it or not?

This drug development is crazy, a potential drug steals for years before it gets authorized.

I blame the Finnish officials in this regard even now. If I lie with power, of course I would allow this product to be used at my own risk.

I know biochemist Markku Jalkanen well and probably the wife of Academy Research Fellow Professor Sirpa has the brain capacity for this project"

But the fact her name is connected to the development of traukamine.. so whoever will discuss this know she wouldn't back a bad drug and ruin her reputation

I put it through Google translate!

"just lacking sales permit"

This is why finland are waking up here and buying in...

Also remember who !markus wife is, and she is on finlands scientific board

The Traumakine drug from Turku-based drug development company Faron Pharmaceuticals is wanted as the last resort in the intensive care of coronavirus patients. The address, created on Thursday, has been signed by about 250 people by Friday night.

The address requires Fimea , the National Agency for Safety and Development, to authorize the use of the medicine as soon as possible to treat serious cases with the patient's consent.

- This drug has the potential to save hundreds, if not thousands of lives in Finland, justifying the address.

Traumakine is developed for the treatment of respiratory failure syndrome, ARDS. The medicine has not been authorized by Fimea.

The problem was the Phase 3 study in 2018, which did not produce the desired results. There was no statistical difference in mortality in patients treated with Traumakine or placebo.

According to Fimea, positive results from a new study would be needed to demonstrate the efficacy and safety of the product.

- The public statement that 'the drug has no side effects' is also incorrect. All medicines have side effects. Traumatic efficacy and safety in the treatment of acute ARDS should be demonstrated in a randomized controlled trial - not yet conducted. Thus, it is clearly premature to say that the medicinal product is "unauthorized", the Fimea website states.

Thanks matey, very interesting

I like that google serchescare picking up the interest in Finland, seems Faron are well on the radar over there

Fast track coming

Do you have a link please ?

https://yle.fi/uutiset/osasto/selkouutiset/sunnuntai_2232020_radio/11270182?origin=rss

How do you know this rumour?

"...future Traumakine trials (including INTEGRITY and CALIBER) are likely to be funded through a third party or parties"

Might see this happening sooner rather than later as big pharmas will want to cash in on the increase cases of ARDs

So what other immunotherapy pharmas work with clevegen?

"Partnering discussions continued with the aim of supporting expansion of clinical development and exploring the potential of Clevegen in combination with existing immunotherapies and other cancer therapies"

After shares for mr 10k

Mr 10,00 shares buyscagain

3 lots today

Slowly slowly catch a monkey

Breakout to level up with the Naz

Get in now

Up she rises